Boundless Bio, Inc. (BOLD)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for Boundless Bio, Inc.. Most notable: 2026-06-25: TANG KEVIN (ten_percent_owner) bought $362k of stock; 2026-06-23: Filed 8-K disclosing material agreement, director or officer change; 2026-06-26: TANG KEVIN (ten_percent_owner) bought $191k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Insider purchase
    TANG KEVIN (ten_percent_owner) bought $158k of stock
  3. Insider purchase
    TANG KEVIN (ten_percent_owner) bought $191k of stock
  4. Insider purchase
    TANG KEVIN (ten_percent_owner) bought $362k of stock
  5. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-29TANG KEVINten percent ownerP7772.48$1,927
2026-06-29TANG KEVINten percent ownerP63,9852.47$158,043
2026-06-26TANG KEVINten percent ownerP75,0472.55$191,370
2026-06-26TANG KEVINten percent ownerP1342.54$340
2026-06-25TANG KEVINten percent ownerP5102.56$1,306
2026-06-25TANG KEVINten percent ownerP145,8802.48$361,782

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Boundless Bio, Inc. (BOLD): insider trades, federal contracts, lobbying | IP Files